These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37172371)

  • 1. Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case report.
    Manzano GS; Rice DR; Zurawski J; Jalkh Y; Bakshi R; Mateen FJ
    J Neuroimmunol; 2023 Jun; 379():578099. PubMed ID: 37172371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fingolimod in Multiple Sclerosis and Familial Mediterranean Fever Coexistence.
    Diker S
    Neurol India; 2022; 70(1):392-394. PubMed ID: 35263925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis.
    Ozdogan H; Ugurlu S; Uygunoglu U; Tutuncu M; Gul A; Akman G; Siva A
    Mult Scler Relat Disord; 2020 Oct; 45():102332. PubMed ID: 32645635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?
    Akman-Demir G; Gul A; Gurol E; Ozdogan H; Bahar S; Oge AE; Gurvit H; Saruhan-Direskeneli G; Yazici H; Eraksoy M
    J Neurol; 2006 Jul; 253(7):928-34. PubMed ID: 16511642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple sclerosis and familial Mediterranean fever: a case report].
    Guinet A; Grateau G; Nifle C; Rozier A; Pico F
    Rev Neurol (Paris); 2008 Nov; 164(11):943-7. PubMed ID: 18808786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumefactive demyelinating CNS lesion in a 60-year-old woman with familial Mediterranean fever.
    Trostel C; Laichinger K; Hauser TK; Saur S; Krumbholz M; Henes J; Ziemann U; Kowarik MC
    Wien Med Wochenschr; 2022 Nov; 172(15-16):379-382. PubMed ID: 34731365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial coexistence of demyelinating diseases and familial Mediterranean fever.
    Korkmaz C; Üsküdar Cansu D; Kabay SC
    Rheumatol Int; 2022 Jan; 42(1):167-173. PubMed ID: 33715072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis.
    Demir CF; BALGETiR F; Ethemoğlu Ö; Aksoy D; Aktaş F; Koca SS; Yetkin MF; Taşci İ
    Arch Rheumatol; 2021 Jun; 36(2):219-226. PubMed ID: 34527926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Mediterranean fever and multiple sclerosis.
    Topçuoğlu MA; Karabudak R
    J Neurol; 1997 Aug; 244(8):510-4. PubMed ID: 9309558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
    Babaoglu H; Varan O; Kucuk H; Atas N; Satis H; Salman R; Ozturk MA; Goker B; Tufan A; Haznedaroglu S
    J Clin Rheumatol; 2020 Jan; 26(1):7-13. PubMed ID: 30048391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
    Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y; Gezer HH; Duruöz MT
    Rheumatol Int; 2022 Jan; 42(1):81-86. PubMed ID: 34550430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S; Dogantan S; Edeer Karaca N; Aksu G; Kutukculer N
    Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
    Bilgen SA; Kilic L; Akdogan A; Kiraz S; Kalyoncu U; Karadag O; Ertenli I; Dogan I; Calguneri M
    J Clin Rheumatol; 2011 Oct; 17(7):358-62. PubMed ID: 21946459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Colchicine on the Histopathological Findings of Celiac Disease During Familial Mediterranean Fever Treatment.
    Alpcan A; Gülerman HF; Kandur Y; Tursun S; Zengin M
    Pediatr Dev Pathol; 2022; 25(4):470-473. PubMed ID: 35316607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
    Özçakar ZB; Özdel S; Yılmaz S; Kurt-Şükür ED; Ekim M; Yalçınkaya F
    Clin Rheumatol; 2016 Feb; 35(2):441-6. PubMed ID: 25213327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Mediterranean Fever without Fever.
    Hotta Y; Kawasaki T; Kotani T; Okada H; Ikeda K; Yamane S; Yamada N; Sekoguchi S; Isozaki Y; Nagao Y; Murotani M; Oyamada H
    Intern Med; 2020 May; 59(10):1267-1270. PubMed ID: 32051376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of canakinumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: A single-centre observational study.
    Tomokawa T; Koga T; Endo Y; Michitsuji T; Kawakami A
    Mod Rheumatol; 2022 Jul; 32(4):797-802. PubMed ID: 34897516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.